Europe Needle-Free Injection Systems Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle-free Injectors, Projectile-based Needle-free Injectors, and Powder-Based Needle-free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)
The Europe needle-free injection systems market is expected to grow from US$ 43.78 million in 2022 to US$ 114.76 million by 2028; it is estimated to grow at a CAGR of 17.4% from 2022 to 2028.
Rising Demand for Vaccines and Biosimilars to Fuel Europe Needle-Free Injection Systems Market
The use of biosimilars is increasing in the treatment of various ailments such as cancer, hepatitis, diabetes, and several other acute and chronic diseases. With the rising prevalence of these illnesses, the need for biosimilars is also increasing, which is presenting a huge opportunity for pharmaceutical & MedTech manufacturers to develop innovative delivery solutions for biosimilars. As several biosimilars and vaccines are administered through injections, the use of needle-free injection technology can provide an easy-to-use and safe method for administering biosimilars without a traditional injection apparatus or skilled staff. Further, many biopharmaceutical manufacturers, vaccine companies, and needle-free device manufacturers are entering into strategic acquisitions and collaborations to leverage the growth potential in the vaccine market. Therefore, the launch of effective and safe drug delivery devices using needle-free injection technology may boost the market growth in the coming years. For instance, in January 2019, Enesi Pharma and Geovax collaborated on multiple vaccines administered using Implavax needle-free injection devices. Also, in August 2021, PharmaJet partnered with Zydus Cadila for the world’s first plasmid DNA COVID-19 vaccine delivery via needle-free injection. In addition, the company also partnered with Abnova to produce and supply the COVID-19 mRNA vaccine using needle-free injection technology. Many patients have a phobia for needles, which has led to the low demand for injectable devices; as a result, many companies are now aiming to develop needle-free injectors with effective and painless solutions. Thus, all these factors encouraging the ease-to-use benefit of these injectors will provide more opportunities for the companies to develop innovative products, which is expected to boost the growth of the Europe needle-free injection systems market during the forecast period.
Europe Needle-Free Injection Systems Market Overview
The Europe needle-free injection systems market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Countries such as France and Germany are expected to be the most significant contributors to the needle-free injection system market due to needlestick injuries and diabetes in the region. International Diabetes Federation (IDF) estimated that diabetes prevalence (9.2%) and the number of people with diabetes (61 million) in Europe will increase by 13% by 2045. Sharps injuries, particularly needlestick injuries, increase the risk of potentially life-threatening infections. Every year in Europe, approximately 1.2 million needlestick injuries are suffered by healthcare staff. More than 30 dangerous blood-borne pathogens are transmitted by contaminated needles, including hepatitis B, hepatitis C, and HIV.
Further, Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the needle-free injection system market. The increasing need for self-administration of drugs in the case of diseases such as diabetes has enhanced the size of the needle-free drug delivery devices industry in Germany. Further, as the prevalence of asthma and other diseases increases across Germany, the demand for inhalers is also expected to rise, which, in turn, drives the needle-free injection system market growth.
Europe Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Europe Needle-Free Injection Systems Market Segmentation
The Europe needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the Europe needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.
Based on technology, the Europe needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.
Based on type, the Europe needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.
Based on durability, the Europe needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.
Based on site of delivery, the Europe needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.
Based on application, the Europe needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.
Based on end user, the Europe needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.
Based on country, the Europe needle-free injection systems market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the market in 2022.
Aijex Pharma International Inc., Crossject, Ferring B.V., Medical International Technologies (MIT Canada) Inc., NuGen Medical Devices, and Zealand Pharma A/S are the leading companies operating in the Europe needle-free injection systems market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Needle Free Injection Systems Market – By Product
1.3.2 Europe Needle Free Injection Systems Market – By Technology
1.3.3 Europe Needle Free Injection Systems Market – By Type
1.3.4 Europe Needle Free Injection Systems Market – By Usability
1.3.5 Europe Needle Free Injection Systems Market – By Site of Delivery
1.3.6 Europe Needle Free Injection Systems Market – By Application
1.3.7 Europe Needle Free Injection Systems Market – By End User
1.3.8 Europe Needle Free Injection Systems Market – By Country
2. Europe Needle Free Injection Systems Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Needle Free Injection Systems Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Needle Free Injection Systems Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
5.1.2 Advantages of Using Self-injection Devices
5.2 Market Restraints
5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
5.3 Market Opportunities
5.3.1 Rising Demand for Vaccines and Biosimilars
5.4 Future Trends
5.4.1 Surge in New Technologies for Needle Free Injection System
5.5 Impact Analysis
6. Needle Free Injection System Market – Europe Analysis
6.1 Europe Needle Free Injection System Marker Revenue Forecast and Analysis
7. Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Product
7.1 Overview
7.2 Europe Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
7.3 Fillable Needle Free Injectors
7.3.1 Overview
7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
7.4 Prefilled Needle Free Injectors
7.4.1 Overview
7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Technology
8.1 Overview
8.2 Europe Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
8.3 Jet-Based Needle-Free Injectors
8.3.1 Overview
8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Spring-Based Needle-Free Injectors
8.4.1 Overview
8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Microarray Patch Injectors
8.5.1 Overview
8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)
9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Type
9.1 Overview
9.2 Europe Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
9.3 Liquid-Based Needle-Free Injectors
9.3.1 Overview
9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.4 Projectile-Based Needle-Free Injectors
9.4.1 Overview
9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.5 Powder-Based Needle-Free Injectors
9.5.1 Overview
9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
10. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Usability
10.1 Overview
10.2 Europe Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
10.3 Disposable
10.3.1 Overview
10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
10.4 Reusable
10.4.1 Overview
10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)
11. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Site of Delivery
11.1 Overview
11.2 Europe Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
11.3 Subcutaneous Injectors
11.3.1 Overview
11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.4 Intramuscular Injectors
11.4.1 Overview
11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.5 Intradermal Injectors
11.5.1 Overview
11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)
12. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 – By Application
12.1 Overview
12.2 Europe Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
12.3 Vaccine Delivery
12.3.1 Overview
12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.4 Insulin Delivery
12.4.1 Overview
12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.5 Pain Management
12.5.1 Overview
12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
12.6 Oncology
12.6.1 Overview
12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.7 Dermatology
12.7.1 Overview
12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.8 Others
12.8.1 Overview
12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)
13. Europe Needle Free Injection Systems Market Analysis– By End User
13.1 Overview
13.2 Europe Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
13.3 Pharmaceutical and Biotechnology Companies
13.3.1 Overview
13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.4 Hospitals
13.4.1 Overview
13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.5 Research Laboratories
13.5.1 Overview
13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.6 Home Care Settings
13.6.1 Overview
13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.7 Other End User
13.7.1 Overview
13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
14. Europe Needle Free Injection Systems Market Revenue and Forecasts to 2028 – Country Analysis
14.1 Overview
14.1.1 Europe: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
14.1.1.1 Germany: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.1.1 Germany: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.1.2 Germany: Needle Free Injection System Market, by Product, 2019–2028 (US$ Thousand)
14.1.1.1.3 Germany: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.1.4 Germany: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.1.5 Germany: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.1.6 Germany: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.1.7 Germany: Needle Free Injection System Market, by Application, 2019–2028 (US$ Thousand)
14.1.1.1.8 Germany: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
14.1.1.2 France: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.2.1 France: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.2.2 France: Needle Free Injection System Market, by Product, 2019–2028 (US$ Thousand)
14.1.1.2.3 France: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.2.4 France: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.2.5 France: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.2.6 France: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.2.7 France: Needle Free Injection System Market, by Application, 2019–2028 (US$ Thousand)
14.1.1.2.8 France: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
14.1.1.3 UK: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.3.1 UK: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.3.2 UK: Needle Free Injection System Market, by Product, 2019–2028 (US$ Thousand)
14.1.1.3.3 UK: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.3.4 UK: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.3.5 UK: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.3.6 UK: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.3.7 UK: Needle Free Injection System Market, by Application, 2019–2028 (US$ Thousand)
14.1.1.3.8 UK: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
14.1.1.4 Italy: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.4.1 Italy: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.4.2 Italy: Needle Free Injection System Market, by Product, 2019–2028 (US$ Thousand)
14.1.1.4.3 Italy: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.4.4 Italy: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.4.5 Italy: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.4.6 Italy: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.4.7 Italy: Needle Free Injection System Market, by Application, 2019–2028 (US$ Thousand)
14.1.1.4.8 Italy: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
14.1.1.5 Spain: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.5.1 Overview
14.1.1.5.2 Spain: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.5.3 Spain: Needle Free Injection System Market, by Product- 2019–2028 (US$ Thousand)
14.1.1.5.4 Spain: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.5.5 Spain: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.5.6 Spain: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.5.7 Spain: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.5.8 Spain: Needle Free Injection System Market, by Application- 2019–2028 (US$ Thousand)
14.1.1.5.9 Spain: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
14.1.1.6 Rest of Europe: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.6.1 Overview
14.1.1.6.2 Rest of Europe: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
14.1.1.6.3 Rest of Europe: Needle Free Injection System Market, by Product- 2019–2028 (US$ Thousand)
14.1.1.6.4 Rest of Europe: Needle Free Injection System Market, by Technology, 2019–2028 (US$ Thousand)
14.1.1.6.5 Rest of Europe: Needle Free Injection System Market, by Type, 2019–2028 (US$ Thousand)
14.1.1.6.6 Rest of Europe: Needle Free Injection System Market, by Usability, 2019–2028 (US$ Thousand)
14.1.1.6.7 Rest of Europe: Needle Free Injection System Market, by Site of Delivery, 2019–2028 (US$ Thousand)
14.1.1.6.8 Rest of Europe: Needle Free Injection System Market, by Application- 2019–2028 (US$ Thousand)
14.1.1.6.9 Rest of Europe: Needle Free Injection System Market, by End User, 2019–2028 (US$ Thousand)
15. Needle-Free Injection System Market–Industry Landscape
15.1 Overview
15.2 Growth Strategies Done by the Companies in the Market (%)
15.3 Organic Developments
15.3.1 Overview
15.4 Inorganic Developments
15.4.1 Overview
16. Company Profiles
16.1 Crossject
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Zealand Pharma A/S
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Medical International Technologies (MIT Canada) Inc.
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 NuGen Medical Devices
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Ferring B.V.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Aijex Pharma International Inc.
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
17. Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 2. Germany: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Germany: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Germany: Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Germany: Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. France: Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. France: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. France: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. France: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 13. France: Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 14. France: Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. UK: Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 16. UK: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Thousand)
Table 17. UK: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 18. UK: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 19. UK: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 20. UK: Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 21. UK: Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Italy: Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Italy: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Italy: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Italy: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 26. Italy: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Italy: Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 28. Italy: Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 29. Spain Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 30. Spain: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Thousand)
Table 31. Spain: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 32. Spain: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 33. Spain: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 34. Spain Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 35. Spain Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 36. Rest of Europe Needle Free Injection System Market, by Product – Revenue and Forecast to 2028 (US$ Thousand)
Table 37. Rest of Europe: Needle Free Injection System Market, by Technology – Revenue and Forecast to 2028 (US$ Thousand)
Table 38. Rest of Europe: Needle Free Injection System Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 39. Rest of Europe: Needle Free Injection System Market, by Usability – Revenue and Forecast to 2028 (US$ Thousand)
Table 40. Rest of Europe: Needle Free Injection System Market, by Site of Delivery– Revenue and Forecast to 2028 (US$ Thousand)
Table 41. Rest of Europe Needle Free Injection System Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 42. Rest of Europe Needle Free Injection System Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 43. Organic Developments Done by Companies
Table 44. Inorganic Developments Done by Companies
Table 45. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Needle Free Injection Systems Market Segmentation
Figure 2. Europe Needle Free Injection Systems Market, By Country
Figure 3. Europe Needle Free Injection Systems Market Overview
Figure 4. Fillable Needle-Free Injectors Segment Held Largest Share of Product Segment in Europe Needle Free Injection Systems Market
Figure 5. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Needle Free Injection Systems Market Impact Analysis of Driver and Restraints
Figure 8. Europe Needle Free Injection System Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Europe Needle Free Injection Systems Market, by Product 2022 & 2028 (%)
Figure 10. Fillable Needle Free Injectors: Revenue and Forecasts to 2028 (US$ Thousand)
Figure 11. Prefilled Needle Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 12. Europe Needle Free Injection Systems Market, by Technology 2022 & 2028 (%)
Figure 13. Jet-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 14. Spring-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 15. Microarray Patch Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 16. Others - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 17. Europe Needle Free Injection Systems Market, by Type 2022 & 2028 (%)
Figure 18. Liquid-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 19. Projectile-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 20. Powder-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. Europe Needle Free Injection Systems Market, by Usability 2022 & 2028 (%)
Figure 22. Disposable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 23. Reusable - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 24. Europe Needle Free Injection Systems Market, by Site of Delivery 2022 & 2028 (%)
Figure 25. Subcutaneous Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 26. Intramuscular Injector - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 27. Intradermal Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
Figure 28. Europe Needle Free Injection Systems Market, by Application 2022 & 2028 (%)
Figure 29. Vaccine Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 30. Insulin Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 31. Pain Management - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 32. Oncology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 33. Dermatology - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 34. Others - Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 35. Europe Needle Free Injection Systems Market, by End User 2022 & 2028 (%)
Figure 36. Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 37. Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 38. Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 39. Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 40. Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 41. Europe: Needle Free Injection System Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 42. Europe: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
Figure 43. Germany: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 44. France: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 45. UK: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 46. Italy: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 47. Spain: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 48. Rest of Europe: Needle Free Injection System Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 49. Growth Strategies Done by the Companies in the Market (%)
- Aijex Pharma International Inc.
- Crossject
- Ferring B.V.
- Medical International Technologies (MIT Canada) Inc.
- NuGen Medical Devices
- Zealand Pharma A/S
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe needle-free injection systems market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution